Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.

The race is on to find a new treatment before resistance to today’s drugs becomes widespread.

Myriam Mendila describes how Novartis continued supporting cancer patients and healthcare professionals during the pandemic.

Meet Melanoma survivor TJ Sharpe in the first installment of his new blog series on Novartis.com.

Novartis is developing an experimental drug for weight loss.

Novartis researchers leverage in-house startup initiative to begin digital technology research collaboration.

Novartis researchers are using data to accelerate drug development.

People with breast cancer need better medicines that help reduce the risk and anxiety of it returning.